project id: TCGA-BLCA; case submitter id: TCGA-FD-A3SQ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 2.09; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.0; age at index: 62; days to birth: -22687; days to death: 1423; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1946; year of death: 2011; age at diagnosis: 22687; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 3.287671232876712; pack years smoked: 60.0; is ffpe: false; composition: Not Reported; days to collection: 1375; days to sample procurement: 0; initial weight: 180.0; portion submitter id: TCGA-FD-A3SQ-01A-21; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0;